Policy & Regulation
Enanta Pharmaceuticals Completes Enrollment in Two Ongoing Phase 2 Studies
20 March 2019 - - US-based biotechnology company Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) has completed enrollment in two Phase 2 studies, the company said.

The Phase 2 study of EDP-93...
Arrowhead Pharmaceuticals Files IND for Pivotal Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
20 March 2019 - - US-based Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has submitted an Investigational New Drug application to the US Food and Drug Administration for an adaptive Phase 2/3 trial wi...
Cold Genesys Closes USD 22m Series C Financing
20 March 2019 - - US-based clinical-stage biopharmaceutical company Cold Genesys, Inc has closed a USD 22m Series C preferred stock financing, the company said.

New investors participated...
US FDA Accepts BLA Filing of Aimmune Therapeutics' AR101 for Peanut Allergy
20 March 2019 - - US-based biopharmaceutical company Aimmune Therapeutics, Inc.'s (NASDAQ: AIMT) Biologics License Application for AR101 has been accepted for review by the US Food and Drug Admin...
Medela secures lactation care contract with Vizient
20 March 2019 - Medela LLC reported on Tuesday the receipt of a group purchasing contract for its Lactation Care, including breast pumps, from Vizient Inc, health care company.Headquartered in Switzer...
Actinium Pharmaceuticals names Mamata Gokhale as VP, global head
20 March 2019 - Cellular therapies company Actinium Pharmaceuticals Inc (NYSE American:ATNM) reported on Tuesday the election of Mamata Gokhale, PhD, RAC as vice president, global head of its Regulato...